Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications

Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatology online journal 2002-10, Vol.8 (2), p.6-6
Hauptverfasser:	Torres-Rojas, J R, Rondón-Lugo, A, Vidal, Rosa
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral BCG Vaccine - adverse effects BCG Vaccine - therapeutic use Clarithromycin - administration & dosage Clarithromycin - therapeutic use Drug Administration Schedule Female Humans Immunocompetence Infant Lymphatic Diseases - drug therapy Lymphatic Diseases - etiology Lymphatic Diseases - microbiology Mycobacterium bovis - immunology Mycobacterium bovis - isolation & purification Mycobacterium bovis - pathogenicity Skin Diseases - drug therapy Skin Diseases - etiology Skin Diseases - microbiology Tuberculosis - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule and lymphadenopathy after BCG vaccination. These rapidly cleared with administration of clarithromycin.
ISSN:	1087-2108 1087-2108
DOI:	10.5070/D313T6G48B